Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan vs Lansoprazole Bismuth Quadruple Therapy for H. pylori
NCT04674774Unknown
- Sponsor
- Incheon St. Mary's Hospital
- Start
- Mar 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tegoprazan in Helicobacter pylori infection (2 arms), sponsored by Incheon St. Mary's Hospital. Primary endpoint: H. pylori eradication rate. Status: unknown.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04674774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04674774.